Great Novel Therapeutics Biotech & Medicals
Taipei Exchange 7427.TWO
Great Novel Therapeutics Biotech & Medicals Share Price on January 14, 2025: USD 0.96
Great Novel Therapeutics Biotech & Medicals Share Price is USD 0.96 on January 14, 2025, a -50.24% change year over year. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance.
-
Great Novel Therapeutics Biotech & Medicals 52-week high Share Price is USD 2.00 on April 02, 2024, which is 108.60% above the current Share Price.
-
Great Novel Therapeutics Biotech & Medicals 52-week low Share Price is USD 0.96 on January 14, 2025, which is 0.00% below the current Share Price.
-
Great Novel Therapeutics Biotech & Medicals average Share Price for the last 52 weeks is USD 1.38.
Key data
| Date | Share Price | Price to Earnings Ratio (P/E) | Price to Sales Ratio (P/S) | Price to Book Ratio (P/B) |
|---|
Market news
Loading...
Taipei Exchange: 7427.TWO
| CEO | Dr. Chia-Nan Chen |
| IPO Date | July 8, 2021 |
| Location | |
| Headquarters | No.508, Zhongxiao East Road |
| Employees | 19 |
| Sector | Health Care |
| Industries | |
Description
Great Novel Therapeutics Biotech & Medicals engages in the development of drugs for the treatment of advanced and refractory cancers. It develops drugs for cancer immunotherapy, including tumor microenvironment regulators, epigenetic immunoactivators, and immune-regulating multi-kinase inhibitors. The company was formerly known as GNT Biotech & Medicals Corporation. Great Novel Therapeutics Biotech & Medicals was founded in 2013 and is based in Taipei City, Taiwan.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email